Singapore markets closed

Adamis Pharmaceuticals Corporation (ADMP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6710-0.0597 (-8.17%)
As of 02:47PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 111.66M
Enterprise value 83.71M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)5.49
Price/book (mrq)3.24
Enterprise value/revenue 4.70
Enterprise value/EBITDA -1.70

Trading information

Stock price history

Beta (5Y monthly) 1.28
52-week change 352.08%
S&P500 52-week change 323.73%
52-week high 32.3400
52-week low 30.4700
50-day moving average 31.0026
200-day moving average 30.9812

Share statistics

Avg vol (3-month) 36.2M
Avg vol (10-day) 33.17M
Shares outstanding 5148.89M
Implied shares outstanding 6N/A
Float 8147.89M
% held by insiders 11.06%
% held by institutions 110.16%
Shares short (14 Nov 2021) 411.94M
Short ratio (14 Nov 2021) 40.92
Short % of float (14 Nov 2021) 48.06%
Short % of shares outstanding (14 Nov 2021) 48.02%
Shares short (prior month 14 Oct 2021) 49.61M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:17
Last split date 312 Dec 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 0.00%
Operating margin (ttm)-228.83%

Management effectiveness

Return on assets (ttm)-57.21%
Return on equity (ttm)-168.76%

Income statement

Revenue (ttm)17.8M
Revenue per share (ttm)0.14
Quarterly revenue growth (yoy)-12.50%
Gross profit (ttm)1.63M
EBITDA -37.85M
Net income avi to common (ttm)-52.2M
Diluted EPS (ttm)-0.4210
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)28.73M
Total cash per share (mrq)0.19
Total debt (mrq)775.75k
Total debt/equity (mrq)2.25
Current ratio (mrq)4.56
Book value per share (mrq)0.23

Cash flow statement

Operating cash flow (ttm)-36.55M
Levered free cash flow (ttm)-28.99M